Core Viewpoint - Jin Hai Medical Technology (02225) has seen a significant stock price increase, attributed to its collaboration with Medtronic China to launch innovative navigation technology for spinal endoscopy during the 8th China International Import Expo [1] Company Summary - Jin Hai Medical Technology's stock rose over 15% during trading, currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] - The company announced a partnership with Medtronic China to unveil new navigation technology aimed at enhancing precision and intelligence in spinal surgeries [1] Industry Summary - The 8th China International Import Expo will take place from November 5 to 10 in Shanghai, providing a platform for showcasing innovative medical technologies [1] - Medtronic's core business includes the development, manufacturing, distribution, and sales of medical therapies and services across cardiovascular, neuroscience, surgical, and diabetes sectors [1] - Medtronic has participated in the Import Expo for seven consecutive years since its inception in 2018, leveraging the event's influence to accelerate the application of its latest medical innovations [1]
港股异动 | 今海医疗科技(02225)盘中涨超15% 今海医疗携手美敦力亮相进博会 发布导航下脊柱内镜创新技术